In clash over sci­ence and na­tion­al se­cu­ri­ty, Chi­nese ri­val to Il­lu­mi­na strug­gles with US ex­pan­sion

The pitch from Chi­na’s MGI Tech to US labs seems ap­peal­ing: Its DNA se­quenc­ing ma­chines can de­code a genome for around $100, an im­por­tant bench­mark in the world of high-cost re­search.

But more than a year af­ter its US launch, MGI has found a chilly re­cep­tion in a mar­ket that con­tin­ues to be dom­i­nat­ed by Il­lu­mi­na, End­points News learned through a re­view of ear­ly sales da­ta and con­ver­sa­tions with in­dus­try ex­perts.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER